Recalls / Generics / Empagliflozin
Empagliflozin
2 FDA drug recalls involving generic “Empagliflozin”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2023-03-09 | Class II | JARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDC 0597- | Boehringer Ingelheim Pharmaceuticals, Inc. |
| 2022-01-26 | Class II | Jardiance (empagliflozin tablets), 25 mg, 30 tablets (3 blister cards with 10 tablets each), Rx only, Distribu | CARDINAL HEALTHCARE |